Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$75,000.00
Sep 1, 2022
For-profit organization
Improvements to Business Robustness and Supply Chain Resilience
995313
The aim of this project is to implement a tactical approach for saving cash by linking the financial statements to business operation and creating tools to measure business improvements, against set targets and identify opportunities to drive improvement to profitability, business robustness and supply chain resilience.
$75,000.00
Sep 1, 2022
For-profit organization
Prototype Tax Exemption Integration with POS (Point of Sale)
995323
The purpose of this project is to research, prototype, and validate the viability of a novel software service that automatically exempts qualifying customers from certain taxes as appropriate at the POS (Point of Sale).
$10,000.00
Sep 1, 2022
For-profit organization
CIT SheBoot : Financial Due Diligence and Data Room Creation
995396
This NRC IRAP project will be used to conduct financial due diligence, build a data room and secure external capital from investors as an early stage MedTech startup.
$30,000.00
Sep 1, 2022
For-profit organization
Developing processing algorithms for building component models
995399
This project tackles a novel technical challenge in the use of robotic automation for the production and assembly of light-wood-framing building components. The adoption of generic robots removes the restriction on acquiring dedicated special-purpose CNC machinery in the existing production line, thereby creating a scalable and flexible prefabrication solution for the housing industry. Specifically, the goal of the project is to create an AI-assisted pipeline from CAD to Robotic Aided Manufacturing to generate robotic control code, sequencing and motion planning. This project will result in a complete automated software workflow for offline planning and motion control of robotics for building component manufacturing.
$75,000.00
Sep 1, 2022
For-profit organization
Veyetals+ Integrating Vitals into Video Calling
995408
Enhance Remote Monitoring Platform SenSights to help Differentiate, Improve IP & Commercialize using Veyetals technology.
$500,000.00
Sep 1, 2022
For-profit organization
Levelwear Sales Acceleration Project
995410
Introduce and implement new marketing initiatives and sales development models to accelerate the sales and revenue growth of Levelwear
$89,100.00
Sep 1, 2022
Academia
Usability and practical utility factors of virtual cardiac rehabilitation for cardiac rehabilitation patients
995424
This project addresses current gaps in the delivery of virtual care in cardiac rehabilitation (VCR) as identified in the literature. Gaps include: the availability and accessibility of home and telehealth based interventions, including VCR technologies tailored to the needs of older adults, a lack of human-centered design, human-computer interaction, and human factors research in designing health applications for older adults, and a lack of involvement of older adults and healthcare providers in the design of technology solutions. Our project aims to address these gaps by involving patients and healthcare professionals in the co?design of tools and systems from the onset, in order to better address their needs and preferences and to encourage greater uptake of cardiac rehabilitation and technology adoption.
$5,176,172.00
Sep 1, 2022
For-profit organization
COVID-19 Rapid Response: Assessment of the Effect of lung-directed Site-Specific Immunomodulator (SSI) in clinical trial QBKPN-CV-01: Assessment of the Effect of QBKPN Site-Specific Immunomodulator (SSI) on Innate Immunity and COVID-19 Vaccine Immune Response and Maintenance in Adults 65 Years of Age or Older
995430
This project will support a Phase 2, randomized, placebo-controlled clinical trial designed to test the effectiveness of a lung-directed immunomodulator on immune response, restoration of innate immunity and/or reduction of morbidity and mortality from COVID-19 in a test population of adults 65 years of age or older in long term care or assisted living facilities.
$50,000.00
Sep 1, 2022
For-profit organization
Interpreting Patient Dialogs - Phase 2
995435
Doctors spend significant time using their electronic medical records (EMR) which limits their capacity to see patients and is a major contributor to doctor burnout and reduced patient satisfaction. The project aims to reduce the time doctors spend on charting, documentation, and other EMR tasks through automatic data processing with the ultimate goal of improving patient care.
$183,500.00
Sep 1, 2022
For-profit organization
RNA therapeutic using nanoparticle-based platform
995465
QurCan Therapeutics is developing the next generation RNA therapeutics using its proprietary BBB-crossing nanoparticle platform technology to overcome the treatment-resistance in brain tumors.